Chemed Q2 adj EPS $4.84, raises FY22 guidance low-end to $19.30; Roto-Rooter revenue +6%

CHEMED CORP

2022-Q2 EPS reported $8.62 revenue$1,061,837,000

Revenue $531M, down 0.2% YoY; GAAP diluted EPS $4.40 (+25.4%); adjusted diluted EPS $4.84 (+5.2%).
VITAS revenue $298M (-4.5%); ADC 17,315 (-3.8%); admissions -12.5%; adj EBITDA margin 16.7% (-78bps).
Roto-Rooter revenue $233M (+6.0%); adj EBITDA $69.0M (+7.4%); margin 29.6% (+39bps).
FY2022 adjusted EPS guidance raised to $19.30-$19.50 from $19.10-$19.50; VITAS rev. decline 4.5-5.0%, Roto-Rooter growth 5.5-5.7%.
Repurchased 100,000 shares for $49.9M at avg $498.61; entered new $550M credit agreement in June.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.